Brazilian police have confiscated cryptoassets worth $45,000 in a major raid on a protection racket ring that targeted small businesses.

Geologist Claims Deep Claw Marks Found in Brazil's Mysterious Tunnels Were Not Made By Humans Paleontologists, to date, have ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

As a pioneer in diabetes care, Novo Nordisk NVO claims 34% of the USD 80 billion-plus diabetes treatment market and roughly half of the insulin market, itself worth more than USD 15 billion.

Brazil represents one of Novo Nordisk’s top five markets. Image credit: Shutterstock/ hyotographics. Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire across the globe and make inroads into large markets like Brazil.

Danish pharmaceutical company Novo Nordisk plans to introduce its weight-loss drug Wegovy in India earlier than planned to compete with Eli Lilly's Mounjaro. Previously set for 2026, the launch might ...

PITTSBURGH (CN) — Bashing a Biden-era law that gives Medicare the power to directly negotiate the price of certain high-cost prescription drugs, an attorney for the pharmaceutical giant Novo Nordisk ...

Tariff extension to pharma could hit generic drugmakers hardest, given narrow margins and ex-US API sourcing. FDA layoffs, CBER exit, and 503A/503B rule shifts may delay reviews, with GLP-1 ...

Novo Banco SA, a Portuguese lender that’s majority-owned by Lone Star, said it’s continuing to prepare for a possible initial public offering, with no exact timing set yet for a sale. The bank ...

HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Novo Holdings, the controlling shareholder of weight loss drugmaker Novo Nordisk A/S (NYSE:NVO ...